| Clinical Research at PCND and CMA:
pnri THE PCND NEUROSCIENCE RESEARCH INSTITUTE
To
bring patients and their families the most up-to-date and innovative
clinical research for neurological disorders, the founders of PCND and the CMA have established the PCND Neuroscience Research Institute (PNRI).
The Institute seeks to promote innovative high-impact clinical and
translational neuroscience research locally in the Palomar-Pomerado
Health District by conducting major pharmaceutical industry clinical
drug trials, investigator-initiated trials based on the staff members'
research interests, and also imaginative collaborative studies with
local universities in San Diego and other research centers. We are a proud partner and affiliate of the Research Institute at Palomar-Pomerado Health.
PNRI focuses on investigations in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. Please see our list of studies and clinical trials currently seeking new patients at the bottom of the page.
For Pharmaceutical Industry and Neuroscience Researchers:
PNRI
does not act as a CRO or SMO. As a private independent clinical
research site linked to a thriving general neurologic and memory
treatment clinic, we draw upon our unusually large local geriatric
community in Rancho Bernardo, CA to successfully recruit and conduct
studies in aging-related neurologic disorders. If your company is
seeking a new research site with experienced neurologists,
neuropsychologists and other clinical researchers, we would like to
partner with you as a site to conduct your neuroscience trial. Also,
we are seeking to collaborate with academic investigators to conduct
original translational and clinical research with new drug targets and
novel therapies. Given our academic backgrounds, we have broad
neuroscience interests ranging from (but not limited to) therapies and
techniques to modulate synaptic function and neuroplasticity,
neuroimaging and other markers of neurodegenerative diseases to
neuropsychological and other studies of AD, dementia and cognitive
health.
To find our more, please contact us at (858) 674-1289 or send us a message in the email box below.
|
All Clinical Trials Offered at Our Site:
| | STUDY | STATUS
| DESCRIPTION
|
ONE
| Moderate to Severe Alzheimer's Disease | CLOSED TO ENROLLMENT - no more patients needed
| This is a 24-week study using an approved medication for the treatment of Moderate to Severe Alzheimer's disease in patients with MMSE 3-12 not in a nursing home or skilled nursing facility. Visits, study drug, and lab tests all provided at no cost, and there will be compensation for time and travel provided. If you or a loved one has memory loss, please call us for more information on this exciting new study. CALL (858) 674-1289.
|
| | | |
TWO
| Stay tuned, new mild to moderate Alzheimer study early 2012
| call us for more info
(858) 674-1289
| |
| | | | |
THREE
| | | |
TO FIND OUT MORE ABOUT OUR TRIALS, CONTACT US IN THE BOX BELOW
OR CALL (858) 674-1289.